{
    "2021-10-19": [
        [
            {
                "time": "",
                "original_text": "沃森生物：增资广东沃森将主要用于广东沃森建设标准厂房及制剂中心项目",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "增资",
                        "广东沃森",
                        "标准厂房",
                        "制剂中心"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：公司已建成的二价HPV疫苗生产线的设计年产能为1500万剂左右",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "HPV疫苗",
                        "生产线",
                        "年产能"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物：各产品研发、临床试验、生产、批签发和销售等工作均正常开展",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "研发",
                        "临床试验",
                        "生产",
                        "批签发",
                        "销售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华为出手：5万亿板块涨停潮！平安大涨、医药股大反攻",
                "features": {
                    "keywords": [
                        "华为",
                        "5万亿板块",
                        "涨停潮",
                        "平安",
                        "医药股",
                        "反攻"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}